Key result
Cardiovascular implantable electronic devices, including pacemakers, defibrillators, and resynchronization therapies, have improved diagnoses and reduced mortality and morbidity in cardiac patients.
Why the study?
Electronic cardiac medicine has transformed diagnosis and treatment of cardiac disease, but the evolving role and future opportunities of cardiac device therapies require summarization.
The second half of the 20th century witnessed a revolution in electronic medicine similar to that in pharmacology in the decades before. The advent of the implantable pacemaker, implantable cardioverter-defibrillators, cardiac resynchronisation therapies, insertable loop recorders and more, have improved diagnoses and reduced mortality and morbidity in millions of patients suffering from cardiac disease. The possibility to monitor patients continually without need for frequent office visits has the potential to reduce follow-up burden on physicians, facilitate increased use of home-based care and further improve the safety for patients. This review summarises the role of cardiac device therapies today and some of the developments which we can hope for in the nearest future.
No takes yet. Share an insight, caveat, or question.
Auricchio et al. (2010) conducted a review in Cardiac disease. Cardiovascular implantable electronic devices (CIEDs) was evaluated. Cardiovascular implantable electronic devices, including pacemakers, defibrillators, and resynchronization therapies, have improved diagnoses and reduced mortality and morbidity in cardiac patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: